Motivation: Every time I encounter a patient with atrial flutter and hard to control ventricular rates, I wonder why the patient is on the floor and not in an electrophysiology suite. I mean, why should we spend time titrating diltiazem when the ablation procedure (ablation of cavo-tricuspid isthmus) has more than 90% success rate. In fact, general guidelines state that in contrast to a-fib, for patients with recurrent atrial flutter, ablation should be the first-line approach rather than rate control. Ablation, however, is not a good long-term fix if patients with atrial flutter also develop atrial fibrillation, which does not respond well to ablation. I have at times heard of the "flutter fibrillation spectrum." But, how often do patients with atrial flutter actually develop atrial fibrillation in the future?
Paper: "Risk of Stroke in Patients with Atrial Flutter", Biblo, L.A. et. al. Am. J. of Card. (2001) 87: 346-349. http://www.ncbi.nlm.nih.gov/pubmed?term=11165976%20
Methods: In this large retrospective study, the authors scanned Medicare inpatient files in 1984 for patients older than 65 who were diagnosed with atrial flutter or atrial fibrillation without stroke. For control, a 5% random sample of other hospitalized patients were chosen without atrial flutter or fibrillation. Patients were followed for 8 years. The primary endpoints assessed were incidence of stroke and incidence of atrial fibrillation in patients with atrial flutter.
Results:
Subjects: The study followed 17,413 patients with atrial flutter, 337,428 with atrial fibrillation, and 395,147 controls.
Atrial Flutter to Fibrillation Incidence: Patients with atrial flutter developed atrial fibrillation in an almost linear fashion over the 8 year follow-up period. By about 6.5 years of follow-up, half of the initial group of patients with atrial flutter had developed an episode of atrial fibrillation. The top three factors which predicted which patients would develop fibrillation were rheumatic heart disease (Risk Ratio: 1.464, CI: 1.250-1.715)., systemic hypertension (RR: 1.333, CI: 1.267-1.402), and congestive heart failure (RR: 1.243, CI: 1.174-1.316).
Stroke Risk: After adjusting for known risk factors like hypertension, CHF, rheumatic heart disease, DM, and MI, the stroke risk in patients with atrial flutter was greater than controls (RR: 1.406, p < 0.0001). The adjusted stroke risk in patients with atrial fibrillation (RR: 1.642, p < 0.0001) was greater than those with atrial flutter. Importantly, the stroke risk for patients initially with atrial flutter with new onset atrial fibrillation was not significantly different from the stroke risk in patients with atrial fibrillation.
Discussion: I think that this paper nicely illustrates why it is hard to manage atrial flutter. Patients with atrial flutter are at significant risk for atrial fibrillation (about half have atrial fibrillation by about 6.5 years of follow-up). In these patients, going through ablation is questionable since a-fib requires rate-control and anti-coagulation regardless. On the other hand, for the half of patients who do not develop a-fib by seven years, conversion to sinus rhythm through ablation would save them many years of hazards of warfarin anti-coagulation. I think that it is still unclear exactly which subgroup benefits most from ablation. Likely as suggested by the paper, patients with additional risk factors like HTN, CHF, and rheumatic heart disease are likely to go on to develop a-fib. Another point underscored by the paper is that while both atrial flutter and fibrillation have elevated stroke risk, patients with atrial fibrillation are at higher risk than those with flutter. Finally, while the paper is impressive in the large number of subjects tracked, the paper is retrospective in nature and only examines patients older than 65. Also, I have some doubts about how accurately atrial flutter/fibrillation is coded during hospitalizations (!).
Paper: "Risk of Stroke in Patients with Atrial Flutter", Biblo, L.A. et. al. Am. J. of Card. (2001) 87: 346-349. http://www.ncbi.nlm.nih.gov/pubmed?term=11165976%20
Methods: In this large retrospective study, the authors scanned Medicare inpatient files in 1984 for patients older than 65 who were diagnosed with atrial flutter or atrial fibrillation without stroke. For control, a 5% random sample of other hospitalized patients were chosen without atrial flutter or fibrillation. Patients were followed for 8 years. The primary endpoints assessed were incidence of stroke and incidence of atrial fibrillation in patients with atrial flutter.
Results:
Subjects: The study followed 17,413 patients with atrial flutter, 337,428 with atrial fibrillation, and 395,147 controls.
Atrial Flutter to Fibrillation Incidence: Patients with atrial flutter developed atrial fibrillation in an almost linear fashion over the 8 year follow-up period. By about 6.5 years of follow-up, half of the initial group of patients with atrial flutter had developed an episode of atrial fibrillation. The top three factors which predicted which patients would develop fibrillation were rheumatic heart disease (Risk Ratio: 1.464, CI: 1.250-1.715)., systemic hypertension (RR: 1.333, CI: 1.267-1.402), and congestive heart failure (RR: 1.243, CI: 1.174-1.316).
Stroke Risk: After adjusting for known risk factors like hypertension, CHF, rheumatic heart disease, DM, and MI, the stroke risk in patients with atrial flutter was greater than controls (RR: 1.406, p < 0.0001). The adjusted stroke risk in patients with atrial fibrillation (RR: 1.642, p < 0.0001) was greater than those with atrial flutter. Importantly, the stroke risk for patients initially with atrial flutter with new onset atrial fibrillation was not significantly different from the stroke risk in patients with atrial fibrillation.
Discussion: I think that this paper nicely illustrates why it is hard to manage atrial flutter. Patients with atrial flutter are at significant risk for atrial fibrillation (about half have atrial fibrillation by about 6.5 years of follow-up). In these patients, going through ablation is questionable since a-fib requires rate-control and anti-coagulation regardless. On the other hand, for the half of patients who do not develop a-fib by seven years, conversion to sinus rhythm through ablation would save them many years of hazards of warfarin anti-coagulation. I think that it is still unclear exactly which subgroup benefits most from ablation. Likely as suggested by the paper, patients with additional risk factors like HTN, CHF, and rheumatic heart disease are likely to go on to develop a-fib. Another point underscored by the paper is that while both atrial flutter and fibrillation have elevated stroke risk, patients with atrial fibrillation are at higher risk than those with flutter. Finally, while the paper is impressive in the large number of subjects tracked, the paper is retrospective in nature and only examines patients older than 65. Also, I have some doubts about how accurately atrial flutter/fibrillation is coded during hospitalizations (!).
I found out, that taking herbal treatment is the best to get rid of hpv as soon as i feel the symptoms of hpv is appearing, i took the healing process by contacting Dr onokun for natural treatment it works wonders, amazingly ever since I had the herbal treatment i have not feel these horrible disease anymore and my doc told me the virus is gone, i am glad i finally got cured out from this horrible disease. every hpv or herpes patients should also get in touch with this herbalist Dr to get ride of these disease forever his email address; dronokunherbalcure@gmail.com
ReplyDelete